Fundraising Fox株式会社KORTUC
Palo Alto, US · 1 known investors
Find your way into 株式会社KORTUC
Sign up to see every warm intro you have to 株式会社KORTUC
- Paths you didn't know you had: your email and LinkedIn already hold routes to the 株式会社KORTUC team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
KORTUC develops a cancer radiotherapy (code name KRC-01) that uses hydrogen peroxide as a radiosensitizer to treat solid tumors. The company operates in the biopharmaceutical and radiation oncology space.
Founders & leadership
KM
Kazu MatsudaCEO
Board
YO
Yasuhiro OgawaInventor & Medical Advisor
Investors · 1
Frequently asked questions
- What does 株式会社KORTUC do?
- KORTUC develops a cancer radiotherapy (code name KRC-01) that uses hydrogen peroxide as a radiosensitizer to treat solid tumors. The company operates in the biopharmaceutical and radiation oncology space.
- Who are 株式会社KORTUC's investors?
- 株式会社KORTUC's investors include Iyogin Capital.
- Where is 株式会社KORTUC headquartered?
- 株式会社KORTUC is headquartered in Palo Alto, US.